Object. The present study was conducted to estimate the frequency and timing of rebleeding after initial subarachnoid hemorrhage (SAH) from ruptured giant aneurysms.
Because of the sparseness of information related specifically to rebleeding from giant aneurysms, in the present study we examine the frequency of rebleeding and factors that may be associated with recurrent hemorrhage of ruptured giant aneurysms in our patients, who are predominantly a referred population.
CLINICAL MATERIAL AND METHODS
We reviewed the medical records of all patients with ruptured giant intracranial aneurysms who underwent surgical treatment at the Mayo Clinic between October 1973 and May 1996. Four patients who died of the initial hemorrhage or rebleeding while awaiting surgical treatment for their giant aneurysms were also included in the analysis. This study undoubtedly excluded patients who died of SAH but in whom the diagnosis of ruptured giant aneurysm was not made. The total number of patients with ruptured giant aneurysms in this study was 109, representing 25% of all cases of giant aneurysm (ruptured and unruptured) and 5% of all cases of aneurysm treated surgically at the Mayo Clinic during the study period.
Patient Demographic Data
Most of the patients (102 or 94%) included in the present study were referred from other medical centers. The mean age of the patients was 52 years (range 12 weeks-81 years); the majority of patients were in their sixth decade of life. There was a preponderance of female patients, with a female/male ratio of 2:1. A history of hypertension was present in 35% of all patients.
Diagnostic Details
For all patients, there was a history of an acute ictus compatible with SAH. Hemorrhage was confirmed by lumbar puncture, computerized tomography (CT) scanning, or surgical findings. The CT scanning was performed in 101 patients and confirmed the presence of SAH in 83%. Often, the giant aneurysm was demonstrated on CT scanning. With the exception of one patient who had a fatal rehemorrhage at the time of admission and another who died of the effects of the initial hemorrhage before undergoing surgery, cerebral angiographic studies were obtained in all patients and demonstrated an aneurysm in 105 (98%) of the 107 studies. An aneurysm was not identified angiographically in two patients because of complete thrombosis.
Aneurysm Specifications
The 109 ruptured giant aneurysms ranged from 25 to 60 mm in diameter. Eighty-one (74%) of them were located in the anterior and the other 28 (26%) in the posterior circulation ( Table 1 ). The most common site for a ruptured giant aneurysm (30 patients, 28%) was the paraclinoid region of the internal carotid artery (ICA). The next most common site (28 patients, 26%) was the middle cerebral artery. Other sites and characteristics of the aneurysms are summarized in Table 1 . Overall, daughter sacs were noted in 7% of patients, and some degree of intraaneurysm thrombosis was noted in 39%. Single giant aneurysms were found in 106 patients; each of the other three patients harbored bilaterally symmetrical aneurysms. A combination of multiple giant and nongiant aneurysms was found in 17% of patients.
Rebleeding Rate
Rebleeding was suspected at the time of admission to our institution or thereafter when we observed a sudden change in the patient's neurological status, with an alteration in the sensorium or severity of headache [26] after recovery from the effects of the initial hemorrhage. [14, 20] Typically, this was confirmed by lumbar puncture, CT scanning, or surgical findings.
Data from the 109 patients varied with regard to the history of their SAH, including number and dates of previous hemorrhages and time of admission to our institution. Therefore, to simulate as closely as possible a population-based study of rebleeding, we identified a subgroup of 63 patients who were admitted within 7 days of their first hemorrhage from a ruptured giant aneurysm. Data from this subgroup were used to calculate the incidence of rebleeding during the first 2 weeks after admission to our hospital, and life table methods were used to estimate cumulative frequency of rebleeding, with patients being excluded if they died of another cause during the first 2 weeks after admission. To minimize inaccuracy caused by referral bias, [28] the time of admission to our institution rather than the time of initial hemorrhage was used as the reference point (Day 0) in estimating the rebleeding rate.
Follow-Up Evaluation
Information for follow-up evaluation was obtained primarily from medical records, telephone interviews, and written correspondence with patients, their close relatives, and local physicians. Excluding the 20 patients who died at admission, the interval to the latest medical follow up ranged from 2 weeks to 15 years after discharge, with a mean of 1.7 years and a total follow-up time of 148 patient-years for the study. 
RESULTS
Of the 109 patients, 31 (28%) suffered an episode of rebleeding at some point during the study: 25 patients presented with one episode of rebleeding, four with two episodes, and two with three episodes. In one of the 31 patients, the date of first rehemorrhage was not specified. The interval between the initial hemorrhage and the first rehemorrhage was less than 15 days in 19 (63%) of the 30 patients in whom the date of first rehemorrhage was known (Fig. 1) . Of the 63 patients admitted to our institution within 7 days after their initial hemorrhage, nine (14%) suffered a first rehemorrhage at some point after admission. In eight of these nine patients, the first rehemorrhage occurred by the end of the 5th day after admission (Fig. 2) . As shown in Fig. 3 , the incidence of rebleeding among these 63 patients from the day of admission was 4.8% at Day 0, 15.7% at Day 7, and 18.4% at Day 14, with the highest rate of rebleeding found within the first 5 days after admission, before the commencement of the plateau at Day 5. Among the nine patients who rebled in this group, the average time to the first rehemorrhage after admission was 3.4 days, whereas the average time to the first rehemorrhage after the initial SAH was 5.7 days. 
Thirty-three patients underwent lumbar puncture and one of them experienced an episode of rebleeding shortly after this procedure. None of the four patients who underwent preoperative placement of a ventriculoperitoneal shunt (one patient) or external ventricular drain (three patients) experienced rebleeding after the procedure. One patient in our study suffered a fatal episode of rebleeding immediately after cerebral angiography, and another experienced rebleeding from an aneurysm that had recurred at the site of an apparently successful clipping 8 years previously.
With regard to the relationship between intraaneurysm thrombosis and rebleeding, 13 (30%) of the 43 patients who had some degree of thrombosis suffered rebleeding. Of these 13 patients, eight exhibited partially thrombosed aneurysms and the other five showed extensively thrombosed aneurysms.
Three of the nine patients who suffered their first rehemorrhage in our hospital died of the effects of the rehemorrhage. Two of these patients died before and the other died soon after surgical treatment.
DISCUSSION
Several studies have addressed the issue of rebleeding from aneurysms of all sizes. Jane, et al., [7] reported an incidence of 20% within the first 14 days after the initial hemorrhage, whereas Phillips, et al., [14] found a 20% incidence during the first 10 days. Kassell and Torner [8] noted that the cumulative incidence of rebleeding within the first 2 weeks after the initial hemorrhage was 19%, with a risk of 14.1% among patients who had received antifibrinolytic therapy and 26.5% among those who had not. In a more recent report by Rosenørn, et al., [15] the 2-week incidence of rebleeding was determined to be 16.8%. In the present study, the cumulative incidence of rebleeding among 63 patients admitted to our hospital within 1 week after their first hemorrhage from a ruptured giant aneurysm was 18.4% at 14 days after admission. It is essential to recognize that this finding represents the incidence of rebleeding from giant aneurysms in a population of patients composed predominantly of referrals and, for two major reasons, probably underestimates the true incidence of rebleeding in the general population. First, our study excluded those patients with a ruptured giant aneurysm who died of SAH before referral or were not referred because of their poor condition or because they had not undergone angiography to confirm the presence of a giant aneurysm. Second, relatively few patients from the subgroup of 63 were admitted to our hospital within 24 hours after their initial hemorrhage, a period representing the peak interval for rebleeding from aneurysms of all sizes. [5, 8] For these reasons, to minimize referral bias, [28] the reference point used to calculate the rebleeding rate was the time of admission to our institution (Day 0) rather than the time of the initial hemorrhage. As a result, our findings reflect the expected rate of rebleeding after admission among patients suffering ruptured giant aneurysms who were referred to experienced neurosurgeons at medical centers similar to our own. Given the finding that among our patients the rate of rebleeding was 18.4% at 14 days after admission, the absolute rate of rebleeding for ruptured giant aneurysms in the general population is likely to be higher than this and therefore similar to that for smaller aneurysms.
It has been suggested in several studies that unruptured giant and near-giant aneurysms have a higher probability of subsequent rupture than smaller ones, [9, 11, 30] and some pathological [21] and clinical [13] evidence supports the possibility of a greater risk of rerupture among larger aneurysms. This view is contrary to the findings of Torner, et al., [23] who stated that the size of an aneurysm is not significantly associated with the risk for recurrent hemorrhage. Our findings support the opinion that the rate of rebleeding for giant aneurysms is similar to that for smaller lesions. We have no information about the risks of ultra-early rebleeding in patients with giant aneurysms.
Concerning the risks of aneurysm rebleeding with cerebrospinal fluid drainage, Paré, et al., [13] reported rebleeding in 2.4% of patients who underwent lumbar puncture and in 30% of patients who underwent some form of ventricular drainage. In our study, one (3%) of the 33 patients who underwent lumbar puncture experienced rebleeding after the procedure, a rate similar to that reported by Paré, et al., although none of the four patients in whom preoperative shunts were placed experienced rebleeding after the procedure.
Tsementzis, et al., [25] reported that the incidence of cerebral aneurysm rupture during angiography was between 0.02% and 0.48%. Behr, et al., [1] reviewed a series of 30 cases of this rare but often fatal complication. In our study, one patient experienced rebleeding immediately after undergoing angiography, a frequency of 0.93%.
With regard to the occurrence of SAH from recurrent giant aneurysms, we found only one example of this among the 105 patients in our series who underwent surgical treatment. Whether the recurrence of this lesion was due to regrowth from a residual neck, refilling after displacement of the original clip, or development of a new aneurysm from the same arterial segment as the first [3, 4, 10, 16, 17] could not be determined.
Regarding the relationship between giant aneurysm rupture and intraaneurysm thrombosis, growth or rupture of such aneurysms is not precluded by either partial or complete thrombosis. [2, 6, 12, 22, 29] Similarly, rebleeding is not precluded by the presence of thrombus within a giant aneurysm, as indicated by our finding that 13 of the 43 patients in our study who showed some degree of intraaneurysm thrombosis experienced an episode of rebleeding.
In two early series, Locksley [9] and Trumpy [24] reported a mortality rate of approximately 40% for first rehemorrhages for the entire range of aneurysm size. We observed a 33% mortality rate among patients with giant aneurysms who experienced their first rehemorrhage at our hospital.
CONCLUSIONS
The principal finding of the present study is that among patients referred to our institution, rebleeding of giant aneurysms occurred at a rate comparable to that seen in smaller lesions. Rebleeding, which was associated with a mortality rate of 33%, was not precluded by the presence of intraaneurysm thrombus and could not be strongly linked to interventions such as cerebrospinal fluid drainage or cerebral angiography. We believe that neurosurgeons should consider these findings when developing management strategies for patients with ruptured giant aneurysms.
